| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/14/2010 | EP2173336A1 New use of known pharmacologically active chemical compounds |
| 04/14/2010 | EP2173334A1 A method of treating amblyopia |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | EP0831903B1 Connective tissue growth factor |
| 04/14/2010 | CN1777445B Agent for repairing corneal perception |
| 04/14/2010 | CN101693715A Coumarins compound, preparation method and application thereof |
| 04/14/2010 | CN101693087A Method for lowering residual solvent in lutein extract |
| 04/14/2010 | CN101693075A Traditional Chinese medicine for treating senile cataract |
| 04/14/2010 | CN101396339B Novel degradable lacrimal passage plug and preparation method thereof |
| 04/14/2010 | CN101129506B Capsule pill drops for treating electro-optical eye and anti-inflammation detoxication |
| 04/14/2010 | CN101103992B Azithromycin eye drops and preparing process thereof |
| 04/13/2010 | US7696194 Visual function disorder improving agents |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7695720 target VEGFR2 (KDR/flk-1); for treating and preventing tumors |
| 04/13/2010 | CA2430363C Compounds and their uses |
| 04/13/2010 | CA2373634C Isophosphoramide mustard analogs and use thereof |
| 04/13/2010 | CA2360680C Antioxidant compositions and methods for companion animals |
| 04/13/2010 | CA2224217C Pharmaceutically active carotenoids |
| 04/08/2010 | WO2010039939A1 Janus kinase inhibitors for treatment of dry eye and other eye related diseases |
| 04/08/2010 | WO2009156092A3 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors |
| 04/08/2010 | WO2009120615A3 Substituted gamma lactams as therapeutic agents |
| 04/08/2010 | US20100087550 Formulations with a Tertiary Amine Oxide |
| 04/08/2010 | US20100087503 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 04/08/2010 | US20100087486 Methods for using tgf-b receptor inhibitors or activin-like kinase (alk) 5 inhibitors a-83-01 and sb-431542 to treat eye disease and wound healing conditions |
| 04/08/2010 | US20100087474 Materials and methods for enhanced degradation of mutant proteins associated with human disease |
| 04/08/2010 | US20100087397 Use of lipid conjugates in the treatment of conjunctivitis |
| 04/08/2010 | US20100086512 Mucomimetic compositions and uses therefore |
| 04/08/2010 | CA2738520A1 Janus kinase inhibitors for treatment of dry eye and other eye related diseases |
| 04/07/2010 | EP2172474A1 Novel peptide and pharmaceutical use of the same |
| 04/07/2010 | EP2172468A1 Benzimidazolone compounds |
| 04/07/2010 | EP2172453A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY |
| 04/07/2010 | EP2172221A1 Composition for ophthalmic disease associated with hypoxia or ischemia |
| 04/07/2010 | EP2172206A1 The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof |
| 04/07/2010 | EP2172101A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
| 04/07/2010 | EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 04/07/2010 | EP2170345A1 Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 04/07/2010 | EP2170343A1 Treatment of age-related macular degeneration |
| 04/07/2010 | EP2170332A1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 04/07/2010 | EP2170320A1 Use of piperine and derivatives thereof for the therapy of neurological conditions |
| 04/07/2010 | EP1431275B1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN101690816A Medicinal composition of calcium-containing antagonist, A II receptor antagonist and statins |
| 04/07/2010 | CN101690803A Medicinal preparations for treating inner ear diseases by transtympanic administration |
| 04/07/2010 | CN101690720A Carteolol orally disintegrating tablets and preparation method thereof |
| 04/07/2010 | CN101690718A Carteolol hydrochloride pellets, preparation method thereof and preparation thereof |
| 04/07/2010 | CN101690712A Sitafloxacin eye drop and preparation method thereof |
| 04/07/2010 | CN101023945B Use of non-periphery substituted phthalocyaniu metal complex |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7691974 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/06/2010 | US7691973 GFRα3 polypeptides |
| 04/06/2010 | US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 04/06/2010 | US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure |
| 04/06/2010 | CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/06/2010 | CA2459009C Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 04/06/2010 | CA2453383C Piperidine derivatives as nmda receptor antagonists |
| 04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
| 04/01/2010 | WO2010035769A1 Improved antibody molecule |
| 04/01/2010 | WO2010035768A1 Prophylactic or therapeutic agent for retinal diseases comprising polyalkylene glycol as active ingredient |
| 04/01/2010 | WO2010035750A1 Method for producing lipid |
| 04/01/2010 | WO2010035749A1 Method for concentrating lipid |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035675A1 Immunopotentiator or antiallergic agent |
| 04/01/2010 | WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035220A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010008995A3 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 04/01/2010 | WO2009139924A3 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 04/01/2010 | WO2008139845A8 Novel amide derivative |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081707 Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea |
| 04/01/2010 | US20100081696 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 04/01/2010 | US20100081657 Quinoxalines useful as inhibitors of protein kinases |
| 04/01/2010 | US20100081646 Bicyclic heteroaryl inhibitors of pde4 |
| 04/01/2010 | CA2738285A1 Method for producing lipids |
| 04/01/2010 | CA2738282A1 Method for concentrating lipids |
| 04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
| 03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/31/2010 | EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 03/31/2010 | EP2168948A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 03/31/2010 | EP2167102A2 Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection |
| 03/31/2010 | EP2166845A2 Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration |
| 03/31/2010 | CN101687922A methods of treating ophthalmic diseases |
| 03/31/2010 | CN101687795A Neurite formation promoter |
| 03/31/2010 | CN101687014A compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 03/31/2010 | CN101686970A Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 03/31/2010 | CN101684147A moraxella catarrhalis proteins |
| 03/31/2010 | CN101684106A Thiazole onium salt compound and application for treating diseases relative to protein aging thereof |
| 03/31/2010 | CN101684091A cannabinoid receptor ligands |
| 03/31/2010 | CN101683532A Ophthalmic compound medicinal preparation containing hyaluronic acid or sodium hyaluronate |
| 03/31/2010 | CN101683488A Traditional Chinese medicine preparation for treating secretory otitis media and preparation method thereof |
| 03/31/2010 | CN101683458A Application of a traditional Chinese medicine composition in preparation of medicament for treating vertigo |
| 03/31/2010 | CN101683347A Topical preparation containing pazufloxacin and steroidal anti-inflammatory drugs |
| 03/31/2010 | CN101683343A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury |
| 03/31/2010 | CN100596281C Plant extracting liquid capable of relieving eye disease |
| 03/30/2010 | US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 03/30/2010 | US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/30/2010 | US7687502 Substituted quinazoline or pyridopyrimidine derivative |
| 03/30/2010 | US7687483 Phosphorus compounds used for improving permeability of drugs such as anticarcinogenic agents to biological barriers; drug delivery |
| 03/30/2010 | US7687074 Prevent adhesion of pathogens; mixture containing fatty acid, or glycerides thereof |